Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 6,840.00
+410.00 (6.38%)
At close: Jun 4, 2026
Penetrium Bioscience Market Cap
Penetrium Bioscience has a market cap or net worth of 367.46 billion as of June 5, 2026. Its market cap has increased by 446.53% in one year.
Market Cap
367.46B
Enterprise Value
370.71B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,840.00
Market Cap Chart
Since June 3, 2021, Penetrium Bioscience's market cap has increased from 215.74B to 367.46B, an increase of 70.32%. That is a compound annual growth rate of 11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 367.46B | 181.93% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 110.83B |
| P&K Skin Research Center | 55.28B |
| HLB bioStep | 53.62B |
| WOOJUNG BIO | 42.75B |
| DT&CRO CO. | 34.52B |
| C&R Research | 31.61B |
| SLS BIO | 26.89B |
| BioInfra | 15.49B |